CEA, a recommended biomarker for the detection of colorectal cancer recurrence, has a pooled sensitivity of 71% and specificity of 88% when applying a threshold of 5 μg/L, as reported in a meta‐analysis of 23 studies.43 Here, CEACAM5 is linked to colorectal cancer.